NYSE •
Healthcare •
Medical Devices •
Quote as of 05/07/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNYSE
Market Capitalization1,736.88 mln
Float45.40 mln
Earnings Date05/07/2026
EPS
0.21
Overpriced
P / E
169
Highly speculative
Piotroski F-Score
7
/ 9
Strong
Beneish M-Score
-2.47
Borderline
1-Year Forecast
50.75
Exceptional upside
Relative Strength
17
/ 100
Significantly lagging
Business Description
Artivion is a global medical company that develops and supplies a broad range of products designed to treat heart and vascular conditions, including artificial heart valves, stent graft systems, surgical sealants, and preserved human tissue. The company also offers specialized services such as tissue preservation and proprietary coating technologies used by surgeons during complex cardiovascular procedures. Founded in 1984 and based in Kennesaw, Georgia, Artivion sells its products directly to hospitals and healthcare facilities through its own sales team. Previously known as CryoLife, the company rebranded under its current name in January 2022.
